CLC bio

CLC bio, a QIAGEN Company, has announced a new release of CLC Drug Discovery Workbench, an enterprise drug-design platform for medicinal and computational scientists

CLC bio has released an add-on module to CLC Genomics Workbench, which has been developed to help finish the assembly of small genomes

Version 5.5 of Molegro Virtual Docker, an integrated platform for computational drug design available for Windows, Linux and Mac OS X, has been released by CLC bio

CLC bio has released version 5.5 of its CLC Genomics Workbench desktop software, supporting a complete resequencing workflow from read mapping over variant detection to downstream analysis

CLC bio has incorporated the features from its CLC DNA Workbench, CLC RNA Workbench and CLC Protein Workbench desktop software packages into a single commercial workbench

CLC bio has revealed Genomics Gateway, a new framework for visualising, combining and analysing genome data

CLC bio has released version 2.0 of CLC Genomics Server, its enterprise platform for Next Generation Sequencing data analysis

CLC bio has released new versions of its solutions for analysing and visualising next generation sequencing data: CLC Genomics Workbench, version 3.5, and CLC Genomics Server, version 1.5.

CLC bio has released Genomics Workbench version 3.0, for analysis and visualisation of sequencing data. The cross-platform software combines expression analyses with next-generation sequencing, bridging analogue and digital gene expression

CLC bio has released its Next Generation Sequencing (NGS) solution, CLC Genomics Workbench, which incorporates cutting-edge technology and algorithms, while also supporting and integrating with the rest of a typical NGS workflow.